PANTAFOR
General Range

PANTAFOR

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

PANTAFOR Injection by Fortune Labs contains Pantoprazole 40 mg, a proton pump inhibitor (PPI) used to reduce excessive stomach acid production. Pantoprazole works by blocking the gastric proton pump, helping manage acid-related conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and certain gastric hypersecretory disorders. PANTAFOR 40 mg Injection is administered intravenously by healthcare professionals when oral treatment is unsuitable or intravenous therapy is clinically indicated. Supplied in a glass vial with a diluent ampoule, this formulation is part of Fortune Labs' injectable pharmaceutical range. Fortune Labs offers Injection PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. Use strictly under medical supervision.

CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Pantoprazole 40 mg
Packaging Type
Glass Vial with Sterile Water Ampoule and Outer Carton
Packaging Size
1 × 40 mg Injection Vial
Dosage Form
Injection (Lyophilized Powder)
Treatment
Gastroesophageal Reflux Disease (GERD), acid reflux, erosive esophagitis, gastric acid-related disorders, and selected conditions involving excessive
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana
View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?

More General Range